Drs. Maura Di Nicola and Basil Williams join host Dr. Jay Sridhar to discuss the latest ongoing ocular oncology clinical trials for the treatment of uveal melanoma and associated complications of radiation therapy.
Their review begins with the DRCR Retina Network’s Protocol AL, which is studying the use of anti-VEGF agents or corticosteroids to reduce the occurrence of radiation retinopathy and consequent vision loss. Drs. Di Nicola and Williams also offer insights about the use of belzupacap sarotalocan (bel-sar) for early-stage choroidal melanoma (CoMpass trial), as well as adjuvant treatment with darovasertib, a protein kinase C inhibitor.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Podden och tillhörande omslagsbild på den här sidan tillhör American Academy of Ophthalmology. Innehållet i podden är skapat av American Academy of Ophthalmology och inte av, eller tillsammans med, Poddtoppen.
